Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients
- 28 January 2016
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 64 (6), 1265-1273
- https://doi.org/10.1016/j.jhep.2016.01.022
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Vascular hyporesponsiveness to angiotensin II in rats with CCl4‐induced liver cirrhosisEuropean Journal of Clinical Investigation, 2009
- Mechanisms of extrahepatic vasodilation in portal hypertensionGut, 2008
- Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic ratsHepatology, 2007
- Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthaseHepatology, 2007
- Vascular dysfunction in human and rat cirrhosis: Role of receptor-desensitizing and calcium-sensitizing proteinsHepatology, 2007
- Defective RhoA/Rho-Kinase Signaling Contributes to Vascular Hypocontractility and Vasodilation in Cirrhotic RatsGastroenterology, 2006
- Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosisHepatology, 2003
- The hyperdynamic circulation in cirrhosisPharmacology & Therapeutics, 2001
- The Effect of Propranolol on Portal Hypertension in Patients with Cirrhosis: A Hemodynamic StudyHepatology, 1982
- PROPRANOLOL—A MEDICAL TREATMENT FOR PORTAL HYPERTENSION?The Lancet, 1980